Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SN-38 Liposome in Metastatic Colorectal Cancer
NCT00311610Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jan 2006
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of firtecan in metastatic colorectal cancer (mCRC), sponsored by Cancer and Leukemia Group B. Started Jan 2006; status: completed.
02
Drugs
firtecan
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00311610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311610.